SOAR Act of 2025
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
The Supplemental Oxygen Access Reform Act of 2025 (SOAR Act) aims to improve access to and payment for supplemental oxygen therapy under Medicare. It proposes separate, inflation-indexed payments for oxygen and related equipment, supplies, and services, moving them away from the competitive acquisition program. The bill also establishes requirements for electronic prescriptions, beneficiary rights like supplier choice, and protections for respiratory therapists, while aiming to strengthen program integrity through electronic templates and clinical inference.
Key provisions
- Separate, inflation-indexed payments for oxygen and related equipment, supplies, and services under Medicare.
- Exclusion of oxygen and related equipment, supplies, and services from the competitive acquisition program.
- Establishment of electronic templates for oxygen prescriptions.
- Rights for beneficiaries to choose suppliers and receive clear communications.
- Reimbursement for respiratory therapist services.
- Establishment of criteria for oxygen suppliers regarding patient evaluation and education.
- Implementation of clinical inference for oxygen and related equipment, supplies, and services.
- Establishment of protections for individuals receiving oxygen, including supplier choice and grievance procedures.
Who is affected
- Medicare beneficiaries
- Supplemental oxygen suppliers
- Respiratory therapists
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
69 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours